The potential use of biomarkers in ecological risk assessment is explored. The biomarker concept, initially developed to form a basis for studies at the individual/population level, is extended to include community and ecosystem level studies. A strategy is outlined in which biomarkers might be used to assess chemical exposure and the cumulative, adverse effects of toxicants on biota in situ. Protocols for identifying communities, species and populations most at risk are described. The role of biomarkers in the evaluation of the effectiveness of remedial action to alleviate pollution is discussed. It is proposed that, in addition to biomarker measurements on samples obtained from organisms at field sites, biomarker screening tests should be initiated in the laboratory with a range of new chemicals and organisms relevant to the field sites thought to be at risk. This will help to establish links between laboratory-based testing and adverse effects in situ.
Depledge, M.H., Fossi, M.C. (1994). The role of biomarkers in environmental assessment (2). Invertebrates. ECOTOXICOLOGY, 3(3), 161-172 [10.1007/BF00117081].
The role of biomarkers in environmental assessment (2). Invertebrates
FOSSI, M. C.
1994-01-01
Abstract
The potential use of biomarkers in ecological risk assessment is explored. The biomarker concept, initially developed to form a basis for studies at the individual/population level, is extended to include community and ecosystem level studies. A strategy is outlined in which biomarkers might be used to assess chemical exposure and the cumulative, adverse effects of toxicants on biota in situ. Protocols for identifying communities, species and populations most at risk are described. The role of biomarkers in the evaluation of the effectiveness of remedial action to alleviate pollution is discussed. It is proposed that, in addition to biomarker measurements on samples obtained from organisms at field sites, biomarker screening tests should be initiated in the laboratory with a range of new chemicals and organisms relevant to the field sites thought to be at risk. This will help to establish links between laboratory-based testing and adverse effects in situ.File | Dimensione | Formato | |
---|---|---|---|
Depledge e Fossi, 1994.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
841.1 kB
Formato
Adobe PDF
|
841.1 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/17564
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo